The purpose of the Biotoxins (indoor damp and mould) Clinical Pathway is to support decision-making for general practitioners and other medical professionals for the diagnosis, treatment, and management of patients with biotoxin-related illnesses.
The Clinical Pathway is designed specifically for use in the Australian context. It is consistent with international advice and has been developed using guidance from international authorities and medical professional associations.
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.